Thursday, February 22, 2018
New Issue Published Current Cancer Drug Targets Vol 18 issue 3
Related Posts:
Call For Paper
Most Accessed Article: Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions
Open Access Article: A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer
Most Accessed Article: Recent Advances in Site Specific Conjugations of Antibody Drug Conjugates (ADCs)
Highlighted Article: Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening
0 comments:
Post a Comment